BOSUTINIB

8981 reported adverse events

Drug classes: Kinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking BOSUTINIB:

# Side effect Count
0 DIARRHOEA 2078
1 NAUSEA 1020
2 FATIGUE 728
3 VOMITING 544
4 DEATH 538
5 RASH 492
6 PLEURAL EFFUSION 458
7 NEOPLASM PROGRESSION 373
8 DYSPNOEA 364
9 HEADACHE 339
See all common reactions for BOSUTINIB

BOSUTINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CYTOGENETIC ANALYSIS ABNORMAL 110 0.1050
1 PHILADELPHIA CHROMOSOME POSITIVE 67 0.0917
2 CHRONIC MYELOID LEUKAEMIA RECURRENT 22 0.0402
3 SEVERE CUTANEOUS ADVERSE REACTION 9 0.0377
4 GRAFT VERSUS HOST DISEASE IN EYE 8 0.0346
5 CHRONIC MYELOID LEUKAEMIA 148 0.0320
6 BLAST CRISIS IN MYELOGENOUS LEUKAEMIA 38 0.0308
7 CHRONIC MYELOID LEUKAEMIA TRANSFORMATION 12 0.0269
8 CHYLOTHORAX 15 0.0208
9 GENE MUTATION IDENTIFICATION TEST POSITIVE 8 0.0190
See all enriched reactions for BOSUTINIB